Focal nodular hyperplasia of the liver after intraconazole treatment

Journal of Clinical Gastroenterology

Volumn 33, Issue 5, 2001, Pages 418-420

  Wolf, Ronni ^a,d   Wolf, Danny ^b   Kuperman, Solomon ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Pediatric Outpatient Clinic   (Israel)

^c Ultrasound Unit of Imaging   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Focal nodular hyperplasia; Intraconazole; Liver

Indexed keywords

CYPROTERONE ACETATE; ETHINYLESTRADIOL; ITRACONAZOLE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BENIGN TUMOR; CASE REPORT; FEMALE; HUMAN; LIVER HYPERPLASIA; MALIGNANT NEOPLASTIC DISEASE; MYCOSIS; PATHOGENESIS; PRIORITY JOURNAL; ULTRASOUND;

ADULT; ANTIFUNGAL AGENTS; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; ITRACONAZOLE;

EID: 0034752288     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200111000-00016     Document Type: Article

References (59)

1. Morphology of spontaneous and induced neoplasia
2. Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats
3. Effects of separate and combined treatments with gamma radiation and diethylnitrosamine in neonatal rats on the induction of altered hepatocyte foci and hepatic tumors
4. Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine
5. Enhancing effects of phenobarbitone and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat
6. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat
7. Long-term administration of DDT or phenobarbital-Na in Wistar rats
8. Effects of long-term intake of DDT on rats
9. Experimental hepatocellular carcinogenesis
10. Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules
11. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4′-diaminodiphenylmethane: A sequential histologic and histochemical analysis
12. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine
13. Report of a workshop on classification of specific hepatocellular lesions in rats
14. Morphologic findings in liver tissue in mice after long-term administration of the herbicide fomesafan
15. Chronic effects of dietary fumonisin on the heart and pulmonary vasculature of swine
16. Induction of lung and liver tumors by fluoranthene in a preweanling CD-I mouse bioassay
17. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor
18. Chronic toxicity/carcinogenicity study of trans-anethole in rats
19. Morphological reaction patterns of the liver induced by drugs
20. 6-Nitrochrysene is a potent tumorigen in newborn mice
21. A model of bile duct hyperplasia in the rat induced by diethylnitrosamine and selective cytotoxicity
22. Carcinogenic evaluation of estazolam via diet in CD strain Sprague-Dawley rats and B6C3F1 mice for 2 years
23. Liver growth and tumorigenesis in rats
24. Long-term studies on chemically induced liver enlargement in the rat. II. Transient induction of microsomal enzymes leading to liver damage and nodular hyperplasia produced by safrole and Ponceau MX
25. Biochemical changes in liver and blood underlying parenchymal damage of rat liver induced by a dose-dependent effect of drugs before and after development of liver enlargement and nodular hyperplasia
26. Role of thyroid hormones in the control of the synthesis of endoplasmic reticulum in rapidly growing neonatal brain and in the hepatocyte during experimentally induced liver growth and nodular hyperplasia
27. Chronic toxicity of fumonisin in weanling pigs
28. Focal nodular hyperplasia of the liver after clomiphene treatment in a young boy
29. Hepatocellular carcinoma and focal nodular hyperplasia associated with norethandrolone therapy: A case report
30. Hepatic lesions in patients treated with synthetic anabolic steroids
31. Focal nodular hyperplasia and spontaneous hepatic rupture in aplastic anemia treated with oxymetholone
32. Focal nodular hyperplasia associated with the use of a synthetic anabolic androgen
33. Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids
34. Diagnostic imaging of focal nodular hyperplasia of the liver developing during nitrofurantoin therapy
35. Actinomycin D associated hepatic veno-occlusive disease: A report of 2 cases
36. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases
37. Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver
38. Nodular regenerative hyperplasia of the liver in children
39. A new era in antimycotic agents
40. Studies on the antifungal action of potential steroid inhibitors
41. Intraconazole: Pharmacokinetics and indications
42. Drug interactions with intraconazole, fluconazole, and terbinafine and their management
43. Continuous intraconazole treatment of onychomycosis and dermatomycosis: An overview of safety
44. Pharmacokinetics of oral antifungals and their clinical implications
45. Current trends in onychomycosis therapy: A literature review
46. Adverse events associated with intraconazole in 189 patients on chronic therapy
47. Intraconazole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycosis
48. Intraconazole therapy in lymphangitic and cutaneous sporotricosis
49. Clinical and pharmacokinetic investigations of oral intraconazole in the treatment of onychomycosis
50. The use of intraconazole to treat cutaneous fungal infections in children
51. Intraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or invasive chemotherapy for hematological disorders
52. The safety of intraconazole in the diabetic population
53. Intraconazole maintenance treatment of histoplasmosis in AIDS: A prospective, multicenter trial
54. Hepatic injury associated with intraconazole
55. Hepatotoxicity associated with intraconazole
56. Severe cholestasis related to intraconazole for the treatment of onychomycosis
57. Intraconazole-induced acute hepatitis
58. Hepatic drug metabolizing enzyme induction and serum triacylglycerol elevation in rats treated with chlordiazepoxide, griseofulvin, rifampicin and phenytoin
59. Staging of breast cancer: What standards should be used in research and clinical practice?